Study Reveals Previously Unknown Drug-Associated Arrhythmias
To identify medications with potential proarrhythmic association.
To identify medications with potential proarrhythmic association.
Prior to pregnancy, her viral load had been undetectable for more than 2 years.
While DAAs have improved the treatment of chronic HCV infection by eliciting higher rates of sustained virologic response, they also interact with a number of agents that could potentially limit their effectiveness.
The authors described the cases of 3 patients with moderate to severe COVID-19 pneumonia who were treated with 2g of icosapent ethyl administered twice daily via a nasogastric tube.
The comparative study aimed to analyze AEs as well as estimate the associated medical costs for 4 IV iron preparations.
Cross-sectional data from the National Health and Nutrition Examination Survey from 1988 to 1994 and 1999 to 2016 were used for this analysis.
The patient, a 67-year-old female, presented to the emergency department with altered mental status.
The study, which was fully remote and contactless, aimed to evaluate whether early treatment with fluvoxamine reduced the likelihood of clinical deterioration and disease severity in patients with mild COVID-19 illness.
The review included a total of 81 unique trials that reported 1 or more outcomes of interest.
To assess the effectiveness of these therapies on pain reduction and quality of life improvement, study authors searched various databases for randomized or quasi-randomized clinical trials that evaluated these outcomes in fibromyalgia patients.